W. Havers

3.1k total citations
76 papers, 2.1k citations indexed

About

W. Havers is a scholar working on Molecular Biology, Oncology and Neurology. According to data from OpenAlex, W. Havers has authored 76 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 22 papers in Oncology and 18 papers in Neurology. Recurrent topics in W. Havers's work include Neuroblastoma Research and Treatments (18 papers), Ocular Oncology and Treatments (14 papers) and Cancer-related Molecular Pathways (11 papers). W. Havers is often cited by papers focused on Neuroblastoma Research and Treatments (18 papers), Ocular Oncology and Treatments (14 papers) and Cancer-related Molecular Pathways (11 papers). W. Havers collaborates with scholars based in Germany, Austria and Netherlands. W. Havers's co-authors include Lothar Schweigerer, G. Henze, Alfred Reiter, M Zimmermann, Martin Schrappe, Wolfgang Hiddemann, F. Lampert, WD Ludwig, S. Sauter and D. Niethammer and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Oncogene.

In The Last Decade

W. Havers

73 papers receiving 2.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
W. Havers 602 600 577 432 368 76 2.1k
H. Behrendt 419 0.7× 746 1.2× 325 0.6× 259 0.6× 209 0.6× 74 1.5k
Robert R. Chilcote 522 0.9× 565 0.9× 440 0.8× 514 1.2× 253 0.7× 47 2.4k
Hiroaki Goto 634 1.1× 476 0.8× 485 0.8× 364 0.8× 133 0.4× 157 1.7k
Melissa R. Snyder 567 0.9× 114 0.2× 718 1.2× 338 0.8× 142 0.4× 66 3.0k
Tohru Inaba 758 1.3× 120 0.2× 402 0.7× 463 1.1× 311 0.8× 117 1.8k
Isabelle Touitou 870 1.4× 505 0.8× 3.6k 6.3× 210 0.5× 41 0.1× 141 4.9k
R. Becher 1.2k 2.1× 289 0.5× 1.4k 2.5× 658 1.5× 80 0.2× 103 3.1k
Juan Bergua 1.3k 2.2× 364 0.6× 979 1.7× 739 1.7× 117 0.3× 59 2.3k
F. Lampert 1.3k 2.1× 1.4k 2.4× 1.2k 2.0× 407 0.9× 586 1.6× 133 3.3k
Mike Griffiths 1.1k 1.8× 597 1.0× 920 1.6× 332 0.8× 45 0.1× 73 2.8k

Countries citing papers authored by W. Havers

Since Specialization
Citations

This map shows the geographic impact of W. Havers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Havers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Havers more than expected).

Fields of papers citing papers by W. Havers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Havers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Havers. The network helps show where W. Havers may publish in the future.

Co-authorship network of co-authors of W. Havers

This figure shows the co-authorship network connecting the top 25 collaborators of W. Havers. A scholar is included among the top collaborators of W. Havers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Havers. W. Havers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schueler, Andreas O., et al.. (2006). DE NOVO INTRAOCULAR RETINOBLASTOMA DEVELOPMENT AFTER CHEMOTHERAPY IN PATIENTS WITH HEREDITARY RETINOBLASTOMA. Retina. 26(4). 425–431. 10 indexed citations
2.
Schramm, Alexander, Holger Christiansen, W. Havers, et al.. (2004). High activin A-expression in human neuroblastoma: suppression of malignant potential and correlation with favourable clinical outcome. Oncogene. 24(4). 680–687. 20 indexed citations
3.
Fleischhack, G., et al.. (2001). Piperacillin, beta-lactam inhibitor plus gentamicin as empirical therapy of a sequential regimen in febrile neutropenia of pediatric cancer patients. Supportive Care in Cancer. 9(5). 372–379. 30 indexed citations
4.
Pavlaković, Helena, et al.. (2001). Quantification of angiogenesis stimulators in children with solid malignancies. International Journal of Cancer. 92(5). 756–760. 58 indexed citations
5.
Pavlaković, Helena, W. Havers, & Lothar Schweigerer. (2001). Multiple angiogenesis stimulators in a single malignancy: Implications for anti-angiogenic tumour therapy. Angiogenesis. 4(4). 259–262. 49 indexed citations
6.
Ottinger, Hellmut, Carlheinz Müller, Norbert Schmitz, et al.. (2000). Transplant activities in Germany in 1998 - a survey facilitated by the National Registry for Hemopoietic Stem Cell Transplantation. Annals of Hematology. 79(8). 437–443. 1 indexed citations
7.
Ballauff, Antje, et al.. (1999). Chronische Hepatopathien nach Behandlung maligner Erkrankungen bei Kindern. Klinische Pädiatrie. 211(2). 49–52. 3 indexed citations
8.
Ratjen, Félix, W. Havers, & Jörg Braun. (1999). Intrapulmonary protein leakage in immunocompromised children and adults with pneumonia. Thorax. 54(5). 432–436. 14 indexed citations
9.
Dörffel, W, H Lüders, Heinz Marciniak, et al.. (1998). Multinationale Therapiestudie für den Morbus Hodgkin bei Kindern und Jugendlichen GPOH-HD 95.Zwischenbericht nach 2 1/2 Jahren. Klinische Pädiatrie. 210(4). 212–219. 3 indexed citations
10.
Stüben, Georg, Martin Stuschke, Michael H. Kroll, W. Havers, & Horst Sack. (1997). Postoperative radiotherapy of spinal and intracranial ependymomas: analysis of prognostic factors. Radiotherapy and Oncology. 45(1). 3–10. 57 indexed citations
11.
12.
Kvasnicka, Jacob, et al.. (1993). Temporal and regional trends of cancer mortality in West Germany. Radiation and Environmental Biophysics. 32(2). 163–182. 1 indexed citations
13.
Sadony, V., et al.. (1991). Management of Nephroblastoma with Intracardiac Extension: Three Case Reports and Review of the Literature. Pediatric Hematology and Oncology. 8(4). 335–345. 2 indexed citations
14.
Messmer, Elmar P., et al.. (1991). Das Metastasierungsrisiko beim Retinoblastom. Klinische Monatsblätter für Augenheilkunde. 199(11). 319–324. 4 indexed citations
15.
Göbel, U., M. Bamberg, Rainer Haas, et al.. (1989). Nichttestikuläre Keimzelltumoren: Analyse der Therapiestudie MAKEI 83/86 und Protokolländerungen für die Nachfolgestudie. Klinische Pädiatrie. 201(4). 247–260. 4 indexed citations
16.
Havers, W., et al.. (1987). The prognosis of retinoblastoma in terms of globe saving treatment. A computer assisted study. Part I. Ophthalmic Paediatrics and Genetics. 8(2). 77–84. 8 indexed citations
17.
Göbel, U., W. Brandeis, H. Gadner, et al.. (1985). Preliminary Results of the GPO-Trial for Treatment of Non-Testicular Germ-Cell Tumors in Children and Adolescents. Oncology Research and Treatment. 8(3). 178–180. 2 indexed citations
18.
Höpping, W, et al.. (1978). The Treatment of Retinoblastoma (The International Symposium on Retinoblastoma). Japanese Journal of Ophthalmology. 22(3). 420–423. 4 indexed citations
19.
Andler, Werner, et al.. (1978). Renal cell carcinoma following radiation therapy for anadrenal cortical carcinoma. The Journal of Pediatrics. 93(4). 634–636. 6 indexed citations
20.
Havers, W., et al.. (1971). [Exomphalos-macroglossia-gigantism syndrome (Wiedemann-Beckwith syndrome) in three siblings].. PubMed. 183(2). 175–82. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. Behrendt Breakdown of academic impact, for papers by Robert R. Chilcote Breakdown of academic impact, for papers by Hiroaki Goto Breakdown of academic impact, for papers by Melissa R. Snyder Breakdown of academic impact, for papers by Tohru Inaba Breakdown of academic impact, for papers by Isabelle Touitou Breakdown of academic impact, for papers by R. Becher Breakdown of academic impact, for papers by Juan Bergua Breakdown of academic impact, for papers by F. Lampert Breakdown of academic impact, for papers by Mike Griffiths
Rankless by CCL
2026